» Articles » PMID: 26793714

Atomic Coordination Reflects Peptide Immunogenicity

Overview
Specialty Biology
Date 2016 Jan 22
PMID 26793714
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

We demonstrated that the immunological identity of variant peptides may be accurately predicted on the basis of atomic coordination of both unprotonated and protonated tertiary structures, provided that the structure of the native peptide (index) is known. The metric which was discovered to account for this discrimination is the coordination difference between the variant and the index; we also showed that increasing coordination difference in respect to the index was correlated to a correspondingly weakening immunological outcome of the variant. Additionally, we established that this metric quickly seizes to operate beyond the peptide scale, e.g., within a coordination shell inclusive of atoms up to a distance of 7 Å away from the peptide or over the entire pMHC-TCR complex. Analysis of molecular orbital interactions for a range of formal charges further revealed that the N-terminus of the agonists was always able to sustain a stable ammonium (NH[Formula: see text]) group which was consistently absent in antagonists. We deem that the presence of NH[Formula: see text] constitutes a secondary observable with a biological consequence, signifying a change in T cell activation. While our analysis of protonated structures relied on the quantum chemical relaxation of the H species, the results were consistent across a wide range of peptide charge and spin polarization conditions.

Citing Articles

System-agnostic prediction of pharmaceutical excipient miscibility via computing-as-a-service and experimental validation.

Antipas G, Reul R, Voges K, Kyeremateng S, Ntallis N, Karalis K Sci Rep. 2024; 14(1):15106.

PMID: 38956156 PMC: 11219749. DOI: 10.1038/s41598-024-65978-2.

References
1.
Ding Y, Baker B, Garboczi D, Biddison W, Wiley D . Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical. Immunity. 1999; 11(1):45-56. DOI: 10.1016/s1074-7613(00)80080-1. View

2.
Pique C, Ureta-Vidal A, Gessain A, Chancerel B, Gout O, Tamouza R . Evidence for the chronic in vivo production of human T cell leukemia virus type I Rof and Tof proteins from cytotoxic T lymphocytes directed against viral peptides. J Exp Med. 2000; 191(3):567-72. PMC: 2195825. DOI: 10.1084/jem.191.3.567. View

3.
van der Merwe P . The TCR triggering puzzle. Immunity. 2001; 14(6):665-8. DOI: 10.1016/s1074-7613(01)00155-8. View

4.
Anton van der Merwe P, Davis S . Molecular interactions mediating T cell antigen recognition. Annu Rev Immunol. 2003; 21:659-84. DOI: 10.1146/annurev.immunol.21.120601.141036. View

5.
Sundaram R, Sun Y, Walker C, Lemonnier F, Jacobson S, Kaumaya P . A novel multivalent human CTL peptide construct elicits robust cellular immune responses in HLA-A*0201 transgenic mice: implications for HTLV-1 vaccine design. Vaccine. 2003; 21(21-22):2767-81. DOI: 10.1016/s0264-410x(03)00179-8. View